Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives

Archiv der Pharmazie

Volumn 345, Issue 9, 2012, Pages 695-702

  Şentürk, Kerem ^a   Tan, Oya Unsal ^a   Çiftçi, Samiye Yabanoǧlu ^a   Uçar, Gülberk ^a   Palaska, Erhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

2 Pyrazoline; 4,5 Dihydropyrazole; Docking; Monoamine oxidase

Indexed keywords

3 (4 CHLOROPHENYL) 5 (4 FLUOROPHENYL) N METHYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3 (4 CHLOROPHENYL) 5 (4 FLUOROPHENYL) N PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3 (4 CHLOROPHENYL) N ETHYL 5 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) 3 (4 METHOXYLPHENYL) N METHYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) 3 (4 METHOXYPHENYL) N PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) 3 (4 METHYLPHENYL) N PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) N METHYL 3 (4 METHYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) N METHYL 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5 (4 FLUOROPHENYL) N,3 DIPHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; MONOAMINE OXIDASE INHIBITOR; N ALLYL 3 (4 CHLOROPHENYL) 5 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ALLYL 5 (4 FLUOROPHENYL) 3 (4 METHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ALLYL 5 (4 FLUOROPHENYL) 3 (4 METHYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ALLYL 5 (4 FLUOROPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ETHYL 5 (4 FLUOROPHENYL) 3 (4 METHOXYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ETHYL 5 (4 FLUOROPHENYL) 3 (4 METHYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; N ETHYL 5 (4 FLUOROPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; THIOAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; MOLECULAR DOCKING; PREDICTION; PRIORITY JOURNAL;

DRUG DESIGN; HUMANS; ISOENZYMES; LIGANDS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; MONOAMINE OXIDASE INHIBITORS; PROTEIN BINDING; PYRAZOLES; STEREOISOMERISM; THIOAMIDES;

EID: 84866249952     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201100448     Document Type: Article

References (27)

1. J. Wouters, F. Moureau, G. Evrard, J. J. Koenig, S. Jegham, P. George, F. Durant, Bioorg. Med. Chem. 1999, 7 (8), 1683-1693.
2. O. Curet, G. Damoiseau-Ovens, C. Sauvage, N. Sontag, P. Avenet, H. Depoortere, D. Caille, O. Bergis, B. Scatton, J. Affect. Disord. 1998, 51 (3), 287-303.
3. F. Lotufo-Neto, M. Trivedi, M. E. Thase, Neuropsychopharmacology 1999, 20 (3), 226-247.
4. M. B. Youdim, D. Edmondson, K. F. Tipton, Nat. Rev. Neurosci. 2006, 7 (4), 295-309.
5. M. B. Youdim, Y. S. Bakhle, Br. J. Pharmacol. 2006, 147 (Suppl 1), S287-S296.
6. L. Oreland, Monoamine Oxidase: Basic Clin. Aspects 1993, 1, 219-247.
7. M. Ebadi, S. Sharma, S. Shavali, H. El Refaey, J. Neurosci. Res. 2002, 67 (3), 285-289.
8. I. M. Anderson, Br. Med. Bull. 2001, 57 (1), 161-178.
9. J. Knoll, Neurobiology 2000, 8 (2), 179-199.
10. F. Manna, F. Chimenti, A. Bolasco, D. Secci, B. Bizzarri, O. Befani, P. Turini, B. Mondov, S. Alcaro, A. Tafi, Bioorg. Med. Chem. Lett. 2002, 12 (24), 3629-3633.
11. N. Gökhan, A. Yeşilada, G. Ucar, K. Erol, A. A. Bilgin, Arch. Pharm. 2003, 336 (8), 362-371.
12. F. Chimenti, A. Bolasco, F. Manna, D. Secci, P. Chimenti, O. Befani, P. Turini, V. Giovannini, B. Mondovì, R. Cirilli, J. Med. Chem. 2004, 47 (8), 2071-2074.
13. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti, A. Granese, O. Befani, P. Turini, S. Alcaro, F. Ortuso, J. Med. Chem. 2005, 48 (23), 7113-7122.
14. F. Chimenti, S. Carradori, D. Secci, A. Bolasco, B. Bizzarri, P. Chimenti, A. Granese, M. Yanez, F. Orallo, Eur. J. Med. Chem. 2010, 45 (2), 800-804.
15. E. Palaska, M. Aytemir, Eur. J. Med. Chem. 2001, 36 (6), 539-543.
16. N. Das, M. Dhanawat, S. K. Shrivastava, Chem. Pap. 2012, 66 (1), 67-74.
17. M. Karuppasamy, M. Mahapatra, S. Yabanoglu, G. Ucar, B. N. Sinha, A. Basu, N. Mishra, A. Sharon, U. Kulandaivelu, V. Jayaprakash, Bioorg. Med. Chem. 2010, 18, 1875-1881.
18. E. Palaska, F. Aydin, G. Uçar, D. Erol, Arch. Pharm. 2008, 341 (4), 209-215.
19. W. Davey, D. J. Tivey, J. Chem. Soc. (Resumed) 1958, 1, 1230-1236.
20. H. S. Mehra, J. Indian Chem. Soc. 1968, 45, 178-181.
21. N. Mishriky, F. Asaad, Y. Ibrahim, A. Girgis, Pharmazie 1996, 51 (8), 544-548.
22. S. Y. Son, J. Ma, Y. Kondou, M. Yoshimura, E. Yamashita, T. Tsukihara, Proc. Natl. Acad. Sci. 2008, 105 (15), 5739-5744.
23. M. Yáñez, N. Fraiz, E. Cano, F. Orallo, Biochem. Biophys. Res. Commun. 2006, 344 (2), 688-695.
24. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti, A. Granese, S. Carradori, S. Alcaro, F. Ortuso, M. Yáñez, J. Med. Chem. 2008, 51 (16), 4874-4880.
25. M. C. Anderson, F. Hasan, J. M. McCrodden, K. F. Tipton, Neurochem. Res. 1993, 18 (11), 1145-1149.
26. M. M. Bradford, Anal. Biochem. 1976, 72 (1-2), 248-254.
27. F. Hubálek, C. Binda, A. Khalil, M. Li, A. Mattevi, N. Castagnoli, D. E. Edmondson, J. Biol. Chem. 2005, 280 (16), 15761-15766.